Libya vs Venezuela: Access to anti-retroviral drugs, female (%)
Libya
52.0%
in 2023
Venezuela
54.0%
in 2024
Libya rank
116th
Venezuela rank
114th
Access to anti-retroviral drugs, female (%) over time
- Libya
- Venezuela
How they compare
Venezuela currently reports 54.0% against 52.0% in Libya, a difference of 2.0%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Venezuela ahead.
Libya ranks 116th and Venezuela ranks 114th of 141 countries.
Venezuela has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.2% | 18.0% | 8.8% | Venezuela |
| 2010s | 41.6% | 49.2% | 7.6% | Venezuela |
| 2020s | 51.0% | 53.5% | 2.5% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Libya or Venezuela?
- Venezuela, at 54.0% against 52.0% in Libya as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Libya and Venezuela?
- 2.0%, with Venezuela ahead.
- How many years of comparable data are there for Libya and Venezuela?
- 22 years are reported by both, from 2000 to 2021.
- How do Libya and Venezuela rank globally for access to anti-retroviral drugs, female?
- Libya ranks 116th and Venezuela ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.